74 217

Cited 3 times in

Successful treatment of chronic eosinophilic pneumonia with anti-IgE therapy

Authors
Shin, YS; Jin, HJ; Yoo, HS; Hwang, EK; Nam, YH; Ye, YM; Park, HS
Citation
Journal of Korean medical science, 27(10):1261-1264, 2012
Journal Title
Journal of Korean medical science
ISSN
1011-89341598-6357
Abstract
Anti-IgE therapy, using recombinant humanized anti-IgE antibodies, is clinically effective in patients with eosinophil-related disorders such as allergic asthma, allergic rhinitis, and chronic urticaria. Chronic eosinophilic pneumonia tends to respond promptly to systemic corticosteroid therapy, however; relapses are common following corticosteroid tapering. We treated two patients (17- and 19-yr-old males) of chronic eosinophilic pneumonia whose symptoms were cough and dyspnea on exertion. The symptoms were recurrent while tapering off corticosteroid. They were treated with anti-IgE antibody without recurrence for 2 yr and 15 months. Here, we first describe clinical experience of the 2 cases of chronic eosinophilic pneumonia.
DOI
10.3346/jkms.2012.27.10.1261
PMID
23091327
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Allergy
AJOU Authors
신, 유섭유, 혜수예, 영민박, 해심
Full Text Link
Files in This Item:
1261-1264.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse